NDC 0409-6102

Furosemide

Furosemide

Furosemide is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Furosemide.

Product ID0409-6102_0db9b7db-0a1f-4024-b25b-e5edce96c751
NDC0409-6102
Product TypeHuman Prescription Drug
Proprietary NameFurosemide
Generic NameFurosemide
Dosage FormInjection, Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS
Marketing Start Date2005-02-28
Marketing CategoryNDA / NDA
Application NumberNDA018667
Labeler NameHospira, Inc.
Substance NameFUROSEMIDE
Active Ingredient Strength10 mg/mL
Pharm ClassesIncreased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0409-6102-02

25 VIAL, SINGLE-USE in 1 TRAY (0409-6102-02) > 2 mL in 1 VIAL, SINGLE-USE (0409-6102-19)
Marketing Start Date2005-02-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0409-6102-19 [00409610219]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-18

NDC 0409-6102-10 [00409610210]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-03-31

NDC 0409-6102-25 [00409610225]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-10-14

NDC 0409-6102-37 [00409610237]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-19
Marketing End Date2018-06-21

NDC 0409-6102-27 [00409610227]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-10-14

NDC 0409-6102-36 [00409610236]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-19
Marketing End Date2018-06-21

NDC 0409-6102-18 [00409610218]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-18

NDC 0409-6102-04 [00409610204]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-02-28

NDC 0409-6102-26 [00409610226]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-10-14

NDC 0409-6102-20 [00409610220]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-02-18

NDC 0409-6102-02 [00409610202]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2005-02-28

NDC 0409-6102-35 [00409610235]

FUROSEMIDE INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA018667
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2013-11-19
Marketing End Date2018-06-21

Drug Details

Active Ingredients

IngredientStrength
FUROSEMIDE10 mg/mL

OpenFDA Data

SPL SET ID:aaced7a8-c3d7-4d66-8c07-aa407b8b3f35
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1719286
  • 1719290
  • 1719291
  • Pharmacological Class

    • Increased Diuresis at Loop of Henle [PE]
    • Loop Diuretic [EPC]

    NDC Crossover Matching brand name "Furosemide" or generic name "Furosemide"

    NDCBrand NameGeneric Name
    0054-3294FurosemideFurosemide
    0054-3298FurosemideFurosemide
    0054-4297FurosemideFurosemide
    0054-4299FurosemideFurosemide
    0054-4301FurosemideFurosemide
    0054-8297FurosemideFurosemide
    0054-8299FurosemideFurosemide
    0054-8301FurosemideFurosemide
    0378-0208Furosemidefurosemide
    0378-0216Furosemidefurosemide
    0378-0232Furosemidefurosemide
    0404-9861FurosemideFurosemide
    0404-9862FUROSEMIDEfurosemide
    0404-9863FurosemideFurosemide
    0404-9864FUROSEMIDEfurosemide
    0409-1639FurosemideFUROSEMIDE
    0409-6102FUROSEMIDEFUROSEMIDE
    68071-1708FurosemideFurosemide
    68071-1809FurosemideFurosemide
    68071-3273FurosemideFurosemide
    68071-3144FurosemideFurosemide
    68071-3194FurosemideFurosemide
    68071-3148FurosemideFurosemide
    68071-4015FurosemideFurosemide
    68071-4022FurosemideFurosemide
    68071-4349FurosemideFurosemide
    68071-4534FurosemideFurosemide
    0409-9631FurosemideFurosemide
    68071-4445FurosemideFurosemide
    68071-4522FurosemideFurosemide
    68094-867FurosemideFurosemide
    68094-756FurosemideFurosemide
    68788-1966FurosemideFurosemide
    68788-6397FurosemideFurosemide
    68788-6784FurosemideFurosemide
    68788-7265FurosemideFurosemide
    68788-6948FurosemideFurosemide
    68788-9226FurosemideFurosemide
    68788-7354FurosemideFurosemide
    68788-9778FurosemideFurosemide
    69315-116FurosemideFurosemide
    69315-118FurosemideFurosemide
    69315-117FurosemideFurosemide
    69677-204FurosemideFurosemide
    70121-1164FurosemideFurosemide
    70121-1076FurosemideFurosemide
    70121-1163FurosemideFurosemide
    70518-0092FurosemideFurosemide
    70518-0584FurosemideFurosemide
    70518-0120FurosemideFurosemide

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.